Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 1/8/2022
Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I associated neurologic disease
Blood
Volume: 117
Date: 03 2011
Translocator protein PET imaging for glial activation in multiple sclerosis
Journal of Neuroimmune Pharmacology
Volume: 6
Date: 09 2011
TGF-b signaling is altered in the peripheral blood of subjects with multiple sclerosis
Journal of Neuroimmunology
Volume: 230
Date: 11 2011
www.ncbi.nlm.nih.gov/pubmed/16652285?dopt=citation
Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients
Journal of Neuroimmune Pharmacology
Volume: 8
Date: 03 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
Brain
Volume: 136
Date: 09 2013
Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs
Journal of Neuroimmune Pharmacology
Volume: 9
Date: 09 2014
Alternative approach: a systematic review of non-pharmacological non-spastic and non-trigeminal pain management in multiple sclerosis.
Eur J Phys Rehabil Med
Volume: 50
Date: 10 2014
Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2
Journal of Neuroinflammation
Volume: 12
Date: 02 2015
Redox regulation of NF-κB p50 and M1 polarization in microglia
Glia
Volume: 63
Date: 03 2015
www.ncbi.nlm.nih.gov/pubmed/18326816?dopt=citation
Serum proteomic analysis of a pre-symptomatic multiple sclerosis cohort
European Journal of Neurology
Volume: 22
Date: 03 2015